LTR Pharma Limited
LTPLF
$0.27
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 5.24% | 3.03% | -401.65% | -389.32% | -328.89% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -96.68% | -96.60% | 333.38% | 322.98% | 281.57% |
| Change in Net Operating Assets | -- | -- | 535.19% | 523.93% | -- |
| Cash from Operations | -8.52% | -11.04% | -271.06% | -261.81% | -184.55% |
| Capital Expenditure | -- | -- | 0.00% | 0.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00% | 0.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 407.14% | 407.14% | -100.00% | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -322.62% | -322.62% | 100.00% | 100.00% | -- |
| Cash from Financing | 413.63% | 425.63% | -100.00% | -100.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -16.46% | -13.58% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 621.64% | 638.49% | -591.91% | -579.65% | 653.74% |